![](/img/cover-not-exists.png)
CREBBP alterations found in extreme responders to PD-1 inhibition in patients (pts) with refractory solid tumors treated in a phase 1 trials unit
Boni, V., Garcia-Donas, J., Garralda, E., Sanchez-Miguel, C. Muñoz, Calles, A., Rodriguez-Moreno, J.F., Calvo, E.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw363.27
Date:
October, 2016
File:
PDF, 36 KB
english, 2016